公司资料
Vincerx Pharma 股价、新闻与催化剂
- 股票代码:
- VINC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.01 USD (0.00%)
收盘价
最后更新: 2026年10月1日
—
市值
股价为何变动
截至 2026年10月1日，VINC 股价变化不大，收于 $0.0150。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Vincerx Pharma is an oncology company focused on targeted therapies and differentiated cancer medicines. Its strategy has centered on precision oncology and program prioritization.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Vincerx sits in specialty oncology biotechnology.
商业模式特征
The company depends on clinical data, pipeline selection, and the ability to convert oncology science into value.
生物医药行业定位
Vincerx is a small-cap oncology catalyst name whose valuation is highly sensitive to development progress.
未来催化剂
- Vincerx is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live oncology milestone. The market is mainly watching what remains after the unwind.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。